3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo(3.2.0)heptane,
ABT-894,
sofinicline,
Sofinicline,
ABT 894,
799279-80-4,
Sofiniclin,
ABT-894,
UNII-SQC232V4YY,
SQC232V4YY,
CHEMBL238465,
A-422894.0,
Sofinicline [USAN:INN],
Sofinicline (USAN),
A 422894.0;Sofiniclin,
SCHEMBL650488,
A 422894.0,
MBQYQLWSBRANKQ-IMTBSYHQSA-N,
BDBM50224483,
ZINC28866069,
CS-6792,
DB12527,
HY-14824,
D09382,
(1S, 5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diaza-bicyclo[3.2.0]heptane,
(1S,5 S)-3-(5,6-dichloropyridin-3-yl)-3,6-diaza-bicyclo[3.2.0]heptane,
(1S,5S)-3-(5,6-Dichloro-pyridin-3-yl)-3,6-diaza-bicyclo[3.2.0]heptane,
(1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diaza-bicyclo[3.2.0]-heptane,
(1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diaza-bicyclo[3.2.0]heptane,
(1S, 5S)-3-(5,6-Dichloro-pyridin-3-yl)-3,6-diaza-bicyclo[3.2.0]heptane,
(1S,5 S)-3-(5,6-Dichloro-pyridin-3-yl)-3,6-diaza-bicyclo[3.2.0]heptane,
3,6-Diazabicyclo(3.2.0)heptane, 3-(5,6-dichloro-3-pyridinyl)-, (1S,5S)-,
Sofinicline [USAN],
D05RSC,
CID10131048,
A13842,
(1S,5R)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane,